Acerca de

DSPN is excited to partner with our Annual Sponsors, Associate Members and Annual Conference presenters to develop a relevant and timely member education series.

These webinars are open to all DSPN members and staff.

We'll keep you informed on upcoming events!

​

 

​

Recent webinars: 

​

DSPN Annual Sponsor Jazz Pharmaceuticals - specialists in providing solutions for people living with neurological conditions & their caregivers - offered an insightful and informative, no cost online gathering for DSPN Members on April 3rd.

​

More about this educational presentation:

 

Topic: Medical Cannabis: Where are we now?

 

Overview:

Cannabis has been the focus of considerable debate, advocacy, and policy, generating both interest and misinformation.

This presentation will provide an overview of cannabis and cannabinoid terminology, complexity of the cannabis plant and cannabinoid science, current regulations, and web-based resources available for continued learning. 

 

Key Learning Objectives:

• Describe cannabis & cannabinoid terminology.

• Understanding of complexity of the cannabis plant and cannabinoid science.

• Explain known differences between FDA-approved and non-FDA-approved cannabinoid-based products.

• Overview of current regulation of cannabis-based products in the US.

• Share web-based resources for continued learning.

 Presenters & Bios:

• Jennifer L Triemstra, MS, PhD – Associate Medical Director – Cannabinoid Education, US Medical Affairs, Jazz Pharmaceuticals

​

​

​

​

​

• Daniela Sharfstein - Director Government Affairs - Jazz Pharmaceuticals 

 

Jennifer, also known as, “Trie”, is an Associate Director in Medical Affairs for Jazz Pharmaceuticals, leading the Cannabinoid Science Education program.  Trie has been working in the cannabinoid science space for nearly 7 years and was instrumental in building the content for CannabinoidClinical.com educational website and leads the Cannabinoid Education Working Group.  Trie has presented to learners across the United States including scientific and healthcare providers, advocacy groups, medical societies, state government and policy making members, and beyond the US including the UN Commission on Narcotic Drugs. 

Prior to her current role, Trie was a Medical Science Liaison at Greenwich Biosciences, US subsidiary of GW Pharmaceuticals, providing scientific support to develop an FDA-approved cannabidiol therapy for the treatment of seizures associated with epilepsy.  Trie received her Master of Science in Cellular and Molecular Biology from Saint Cloud State University and her PhD in Comparative and Molecular Biosciences at the University of Minnesota, School of Veterinary Medicine. 

​

Daniela Glick Sharfstein serves as Director of State Government Relations for Jazz Pharmaceuticals.  Prior to Jazz, Daniela was a senior consultant for Public Works, LLC where she provided high-level policy development, management, strategic planning, and implementation to state and local governments.  Daniela also served as Deputy Cabinet Secretary of Economic Development, Director of Cabinet Affairs and Deputy Director of Political, Policy and Legislative Affairs for former New Mexico Governor Bill Richardson. Daniela is a senior leader and seasoned public policy, communications, and government relations specialist. 

​

This DSPN Annual Sponsor and Associate member is ready share more fantastic training resources. Please reach out to Brandon Eddy - RN to learn more!

​

Thank you to Jazz Pharmaceuticals for making this webinar and other resources available!